Central retinal artery occlusion can result in permanent vision loss. Effective treatment is lacking. We conducted a phase 3, double-blind, double-dummy, randomized, controlled trial involving ...

A 63-year-old man presented with a 3-month history of chest tightness, palpitations, and abdominal pain. Laboratory studies ...

A number of therapies that have been shown to be effective in patients with chronic heart failure, including beta-blockers, mineralocorticoid receptor antagonists, and renin–angiotensin system ...

The corporatization of the U.S. health insurance industry may contribute to poor health care performance for the commercially insured population, but some supply-side and demand-side reforms could ...

A 50-year-old man presented with a 1-year history of progressive headaches. On examination, there was neck stiffness and dysmetria in both arms. An MRI of the head showed Eiffel-by-night sign.

Rare disease in an adolescent who lived more than 12,000 years ago, along with her burial embrace by a first-degree relative, may reflect the importance of care for survival. Ancient DNA analysis l ...

Corporatization represents a deal between medical organizations and investors and presumably benefits those entities. But the key question for society is whether it benefits patients and payers.

Explore the current issue of The New England Journal of Medicine (Vol. 394 No. 5).

A number of autoimmune diseases that affect diverse organ systems have recently been noted to be related to IgG4 autoantibodies. The authors review the spectrum of IgG4-related disease and the curr ...

A 40-year-old man was referred to the otorhinolaryngology clinic with a 1-month history of a sore throat. Nonulcerated white plaques were present in a butterfly shape across the posterior oropharynx, ...

A 58-year-old woman was admitted to the hospital 3 weeks after lumbar surgery because of diplopia and fever. Left leg pain and a rash had preceded the fever and diplopia. A diagnosis was made.

To the Editor: Harrison et al. (Feb. 8 issue) 1 found that resmetirom treatment reduced levels of free thyroxine (FT4) by approximately 16 to 19% in patients with nonalcoholic steatohepatitis (NASH).